Literature DB >> 3309455

High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease.

Y Wakayama1, S Shibuya, J Kawase, F Sagawa, Y Hashizume.   

Abstract

The measurement of neuron-specific enolase level in serum and cerebrospinal fluid was conducted time-sequentially in an autopsy confirmed patient with Creutzfeld-Jakob disease. The level was markedly high in the early stage of the disease at which time the brain CT showed no or minimal abnormalities, while falling into the normal range in the advanced stage. This is the first report of the elevated level of neuron-specific enolase in Creutzfeldt-Jakob disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3309455     DOI: 10.1007/BF01743256

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  6 in total

1.  Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system.

Authors:  J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

2.  Enolase isoenzyme distribution in the human brain and its tumours.

Authors:  J A Royds; M A Parsons; C B Taylor; W R Timperley
Journal:  J Pathol       Date:  1982-05       Impact factor: 7.996

3.  Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.

Authors:  R P Friedland; S B Prusiner; W J Jagust; T F Budinger; R L Davis
Journal:  J Comput Assist Tomogr       Date:  1984-10       Impact factor: 1.826

4.  Cerebrospinal fluid enolase in stroke.

Authors:  E Hay; J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

5.  Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases.

Authors:  K Mokuno; K Kato; K Kawai; Y Matsuoka; T Yanagi; I Sobue
Journal:  J Neurol Sci       Date:  1983 Aug-Sep       Impact factor: 3.181

6.  Brain levels of neuron-specific and nonneuronal enolase in Huntington's disease.

Authors:  P J Marangos; S M Paul
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372

  6 in total
  4 in total

1.  Magnetic resonance imaging follow-up in Creutzfeldt-Jakob disease.

Authors:  J Röther; A Schwartz; M Härle; K U Wentz; P Berlit; M Hennerici
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

Review 2.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.

Authors:  Allyson Connor; Han Wang; Brian S Appleby; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging.

Authors:  Takaki Murata; Yusei Shiga; Shuichi Higano; Shoki Takahashi; Shunji Mugikura
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

4.  Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.

Authors:  Ilse S Pienaar; Timothy Schallert; Suzél Hattingh; William M U Daniels
Journal:  J Neural Transm (Vienna)       Date:  2009-06-06       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.